|
The role of c-Maf in Stem cells in Leukemia
|
5F31CA162770-02
|
$42,232
|
$21,116
|
Okoye, Ujunwa
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$19,332
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
IL-15 Superagonist Complex as an Immunotherapeutic for Multiple Myeloma
|
1R43CA167925-01A1
|
$231,853
|
$231,853
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$9,723
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$18,240
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-14
|
$95,411
|
$18,128
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S1
|
$300,000
|
$9,000
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S2
|
$139,989
|
$4,200
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
5U10CA139519-03
|
$310,336
|
$9,310
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
|
5R01CA132778-04
|
$264,964
|
$264,964
|
GERA, JOSEPH
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Sensitivity of multiple myeloma cells to mTOR inhibitors
|
2R01CA111448-06A1
|
$184,270
|
$184,270
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-03
|
$131,854
|
$21,097
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-29
|
$728,213
|
$14,564
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$67,422
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Bcl-2 function on the endoplasmic reticulum
|
5R01CA085804-13
|
$284,448
|
$56,890
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S3
|
$4,849,180
|
$48,492
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S4
|
$74,396
|
$744
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-23
|
$326,434
|
$19,586
|
Wilbur, Deborah
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
2U10CA045418-26
|
$1,423,934
|
$28,479
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-25
|
$340,319
|
$54,451
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CCOP: Colorado Cancer Research Program
|
2U10CA067753-17
|
$1,128,806
|
$33,864
|
PAJON, EDUARDO
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Multiple Myeloma and Cancer Therapies via Largazole Analogs
|
5R01CA152314-03
|
$305,856
|
$305,856
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Columbia University Medical Center Minority-Based Community Clinical Oncology Pro
|
1U10CA167791-01
|
$796,302
|
$23,889
|
GRANN, VICTOR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbus Community Clinical Oncology Program (Columbus CCOP)
|
5U10CA035261-29
|
$813,151
|
$40,658
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
|
5R01CA129488-04
|
$744,389
|
$119,102
|
LAPPE, JOAN
|
CREIGHTON UNIVERSITY
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
5P01CA078378-13
|
$1,974,463
|
$1,974,463
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
SPORE in Myeloma
|
5P50CA100707-10
|
$2,300,000
|
$2,300,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-20
|
$278,781
|
$278,781
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$446,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$2,263
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Selective Inhibition of HDAC6 in Cancer Therapy
|
5K08CA128972-05
|
$139,320
|
$139,320
|
BRADNER, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
|
5R01CA151391-03
|
$346,193
|
$346,193
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INSTITUTE
|
|
CXCR4 regulation of tumor progression in Multiple Myeloma
|
5R01CA125690-05
|
$311,124
|
$311,124
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
The role of miRNA15a and 16-1 in Multiple Myeloma
|
5R01CA154648-02
|
$363,125
|
$363,125
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
5U10CA023318-36
|
$2,311,793
|
$439,241
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
Differentiating Agents in Hematologic Malignancies
|
5R01CA042802-25
|
$323,814
|
$161,907
|
KUFE, DONALD
|
DANA-FARBER CANCER INSTITUTE
|
|
Integrative Oncogenomics of Multiple Myeloma
|
5P01CA155258-02
|
$1,999,347
|
$1,999,347
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INSTITUTE
|
|
Homologous Recombination Mediates Genomic Instability and Progression in Myeloma
|
5R01CA124929-05
|
$344,180
|
$344,180
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INSTITUTE
|
|
Dayton Clinical Oncology Program
|
5U10CA035090-30
|
$1,013,114
|
$50,656
|
Gross, Howard
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA045807-27
|
$1,361,380
|
$68,069
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
ECOG - ACRIN CCOP RESEARCH BASE GRANT - CORE
|
2U10CA037403-27
|
$4,068,148
|
$406,815
|
COMIS, ROBERT
|
Drexel University
|
|
Eastern Cooperative Group Chair's Office
|
5U10CA086802-14
|
$629,400
|
$119,586
|
COMIS, ROBERT
|
Drexel University
|
|
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress
|
5R01CA127910-06
|
$311,976
|
$311,976
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
Arsenic-induced apoptosis in myeloma
|
5R01CA129968-04
|
$362,855
|
$362,855
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$59,707
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$3,000
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$5,987
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-29
|
$538,966
|
$21,559
|
Nikcevich, Daniel
|
ESSENTIA INSTITUTE OF RURAL HEALTH
|
Total relevant funding to Multiple Myeloma for this search: $61,283,378
|